- Home
- THRM vs COLL Comparison
THRM vs COLL Comparison
Compare THRM & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRM
- COLL
- Stock Information
- Founded
- THRM 1991
- COLL 2002
- Country
- THRM United States
- COLL United States
- Employees
- THRM N/A
- COLL N/A
- Industry
- THRM Auto Parts:O.E.M.
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- THRM Consumer Discretionary
- COLL Health Care
- Exchange
- THRM Nasdaq
- COLL Nasdaq
- Market Cap
- THRM 997.7M
- COLL 958.8M
- IPO Year
- THRM 1993
- COLL 2015
- Fundamental
- Price
- THRM $36.51
- COLL $39.11
- Analyst Decision
- THRM Buy
- COLL Strong Buy
- Analyst Count
- THRM 3
- COLL 4
- Target Price
- THRM $46.00
- COLL $44.25
- AVG Volume (30 Days)
- THRM 234.5K
- COLL 412.7K
- Earning Date
- THRM 07-24-2025
- COLL 08-07-2025
- Dividend Yield
- THRM N/A
- COLL N/A
- EPS Growth
- THRM N/A
- COLL N/A
- EPS
- THRM 1.02
- COLL 1.06
- Revenue
- THRM $1,453,370,000.00
- COLL $707,007,000.00
- Revenue This Year
- THRM $1.09
- COLL $20.47
- Revenue Next Year
- THRM $3.26
- COLL $2.91
- P/E Ratio
- THRM $34.10
- COLL $36.89
- Revenue Growth
- THRM N/A
- COLL 22.61
- 52 Week Low
- THRM $22.75
- COLL $23.23
- 52 Week High
- THRM $51.73
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- THRM 68.08
- COLL 71.22
- Support Level
- THRM $34.63
- COLL $37.29
- Resistance Level
- THRM $35.88
- COLL $38.50
- Average True Range (ATR)
- THRM 1.02
- COLL 1.22
- MACD
- THRM 0.07
- COLL 0.43
- Stochastic Oscillator
- THRM 97.28
- COLL 92.07
About THRM Gentherm Inc
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.